Literature DB >> 12535755

Hepatitis C virus seropositivity, but not hepatitis B virus carrier or seropositivity, associated with increased pulse wave velocity.

Hirofumi Tomiyama1, Tomio Arai, Ken-ichi Hirose, Sabroh Hori, Yoshio Yamamoto, Akira Yamashina.   

Abstract

Immune mechanisms have important roles in the pathogenesis of atherosclerosis. The present study was conducted to evaluate the association of pulse wave velocity (PWV) with either hepatitis C or B. In 7514 subjects, we determined the PWV, as well as the plasma levels of hepatitis B virus antigen and antibody and of hepatitis C virus antibody. The results of multiple regression analysis showed that seropositivity for hepatitis C virus was a significant variable for PWV independent from atherosclerotic risk factors. Thus, hepatitis C virus seropositivity was associated with increased PWV.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12535755     DOI: 10.1016/s0021-9150(02)00388-x

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  16 in total

1.  Direct-acting antivirals improve endothelial function in patients with chronic hepatitis: a prospective cohort study.

Authors:  Matteo Nicola Dario Di Minno; Pasquale Ambrosino; Antonio Riccardo Buonomo; Biagio Pinchera; Ilenia Calcaterra; Manuel Crispo; Riccardo Scotto; Francesco Borgia; Consalvo Mattia; Ivan Gentile
Journal:  Intern Emerg Med       Date:  2019-08-08       Impact factor: 3.397

2.  The association between hepatitis C infection and prevalent cardiovascular disease among HIV-infected individuals.

Authors:  Matthew S Freiberg; Debbie M Cheng; Kevin L Kraemer; Richard Saitz; Lewis H Kuller; Jeffrey H Samet
Journal:  AIDS       Date:  2007-01-11       Impact factor: 4.177

3.  Impact of DAA-Based Regimens on HCV-Related Extra-Hepatic Damage: A Narrative Review.

Authors:  Evangelista Sagnelli; Caterina Sagnelli; Antonio Russo; Mariantonietta Pisaturo; Clarissa Camaioni; Roberta Astorri; Nicola Coppola
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  The risk of incident coronary heart disease among veterans with and without HIV and hepatitis C.

Authors:  Matthew S Freiberg; Chung-Chou H Chang; Melissa Skanderson; Kathleen McGinnis; Lewis H Kuller; Kevin L Kraemer; David Rimland; Matthew B Goetz; Adeel A Butt; Maria C Rodriguez Barradas; Cynthia Gibert; David Leaf; Sheldon T Brown; Jeffrey Samet; Lewis Kazis; Kendall Bryant; Amy C Justice
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2011-06-28

5.  Association of hepatitis C virus seropositivity with inflammatory markers and heart failure in persons with coronary heart disease: data from the Heart and Soul study.

Authors:  Judith I Tsui; Mary A Whooley; Alexander Monto; Karen Seal; Phyllis C Tien; Michael Shlipak
Journal:  J Card Fail       Date:  2009-02-10       Impact factor: 5.712

Review 6.  Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms.

Authors:  Luigi E Adinolfi; Rosa Zampino; Luciano Restivo; Amedeo Lonardo; Barbara Guerrera; Aldo Marrone; Fabio Nascimbeni; Anna Florio; Paola Loria
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

7.  Is hepatitis C associated with atherosclerotic burden? A systematic review and meta-analysis.

Authors:  He Huang; Rongyan Kang; Zhendong Zhao
Journal:  PLoS One       Date:  2014-09-03       Impact factor: 3.240

Review 8.  Atherosclerosis as a possible extrahepatic manifestation of chronic hepatitis C virus infection.

Authors:  Nobukazu Ishizaka; Yuko Ishizaka; Minoru Yamkado
Journal:  Clin Med Insights Cardiol       Date:  2014-11-12

Review 9.  Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV.

Authors:  Amedeo Lonardo; Stefano Ballestri; Giovanni Guaraldi; Fabio Nascimbeni; Dante Romagnoli; Stefano Zona; Giovanni Targher
Journal:  World J Gastroenterol       Date:  2016-11-28       Impact factor: 5.742

Review 10.  Atherosclerosis as Extrahepatic Manifestation of Chronic Infection with Hepatitis C Virus.

Authors:  Theodoros Voulgaris; Vassilios A Sevastianos
Journal:  Hepat Res Treat       Date:  2016-01-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.